Skip to content

Assessment of vigilance using pupillometry in epilepsy, idiopathic hypersomnia and narcolepsy

Assessment of vigilance using pupillometry in epilepsy, idiopathic hypersomnia and narcolepsy - Vigilance in epilepsy, idiopathic hypersomnia and narcolepsy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47847
Enrollment
90
Registered
2016-07-14
Start date
2019-03-12
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsie epilepsy excessive daytime sleepiness idiopathic hypersomnia Narcolepsy

Interventions

None listed

Sponsors

Stichting Epilepsie Instellingen Nederland
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Subjects are > 18 years Diagnosed in one of the below mentioned categories: 1. Epileptic patients with seizures only during the night for at least the last year 2. Epileptic patients with seizures only during the day for at least the last year 3. Type 1 narcolepsy patients 4. Type 2 narcolepsy patients 5. Idiopathic hypersomnia 6. Healthy controls

Exclusion criteria

Exclusion criteria: - Color vision deficiency - Recent (

Design outcomes

Primary

MeasureTime frame
As the primary endpoint, responsiveness to light will be measured using the pupillometer, measuring the diameter of the pupil while exposed to no light, red light and blue light, resulting in the Post-illumination Pupillary Response (PIPR) (Van der Meijden et al., 2015).

Secondary

MeasureTime frame
Secondary endpoints are vigilance as measured by the SART (total error score Van Schie et al., 2012) and the ESS. In addition, we will assess habitual sleep timing from the MCTQ, fatigue with the FSS and sleep quality from the PSQI.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)